Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00301951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: sargramostim
DRUG: busulfan
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
DRUG: tacrolimus
PROCEDURE: umbilical cord blood transplantation

Sponsor

University of California, San Francisco

Collaborators

[object Object]